Facial Treatment
Study Number: C25-D121
Study Location:
Dallas Research Center: 1801 N. Glenville Dr., Suite 250 Richardson, Texas 75081
Compensation: Up to $425.00
Gender:
Females
Age:
35-65years old (up to 70 for dark skin tones V-VI, and those of Asian race)
Skin Type:
Fitz I-VI
Study Description:
This single-center cosmetic clinical trial is designed to evaluate the efficacy of the Sponsor’s facial treatment over 12 weeks in women with mild to moderate signs of aging, including crow’s feet and under-eye fine lines, reduced cheek softness (tactile), and visual concerns such as uneven texture, enlarged pores, mottled hyperpigmentation, and redness (limited to Fitzpatrick skin types I–III) on the global face
Study Requirements:
Must:
- ✓ Have fine lines on crow’s feet area and under eye area, visual pores, redness on face (Fitz I-III), uneven skin tone on face, lack of softness on cheeks.
Cannot:
- ✕ Have any autoimmune disorders, connective tissue diseases, or immune deficiencies (such as multiple sclerosis, Crohn’s disease, HIV, or rheumatoid arthritis).
Complete the prescreening survey below:
All information you provide will be kept confidential; you may be contacted by telephone or text. The questions in the survey will be used to determine your eligibility for our studies. If you withdraw or do not qualify, your information will be stored for future reference. You can request to have your information disabled at any time, and we will not contact you for future studies.